Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Iraqi H5N1 case confirms diagnostic challenges:

This article was originally published in Clinica

Executive Summary

The demands placed upon diagnostic technologies in relation to controlling the avian flu virus H5N1 were highlighted again today, when the WHO retrospectively confirmed as positive Iraq's third case of the disease. The case, which was reported last March in Baghdad, presented with a mild form of the disease and recovered, but external verification tests proved inconclusive, probably as a result of sample deterioration in light of shipment difficulties. However, "repeated testing, using different methods, was needed for diagnostic confirmation," said the WHO. Two cases had been confirmed as H5N1 in January.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052933

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel